David R. Purdue - 27 Feb 2026 Form 4/A - Amendment Insider Report for AbbVie Inc. (ABBV)

Role
SVP, Controller
Signature
/s/ T.O. Odutayo, Attorney-in-Fact for David R. Purdue
Issuer symbol
ABBV
Transactions as of
27 Feb 2026
Net transactions value
$0
Form type
4/A - Amendment
Filing time
11 Mar 2026, 17:00:20 UTC
Date Of Original Report
03 Mar 2026
Previous filing
20 Feb 2026
Next filing
06 Mar 2026
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Purdue David Ryan SVP, Controller 1 NORTH WAUKEGAN ROAD, NORTH CHICAGO /s/ T.O. Odutayo, Attorney-in-Fact for David R. Purdue 11 Mar 2026 0002057696

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ABBV Common Stock, $0.01 par value Tax liability -2,108 -20% $232.08* 8,468 27 Feb 2026 Direct
holding ABBV Common Stock, $0.01 par value 543 27 Feb 2026 Profit sharing trust F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Balance in AbbVie Savings program as of February 20, 2026. Balance includes shares acquired pursuant to a dividend reinvestment feature.

Remarks:

Amended to correct the number of shares withheld for taxes at vesting as reported on the original Form 4 filed March 3, 2026. The original filing reflected an incorrect withholding rate. All other information remains unchanged.